Search the GHTC website
March 25, 2024

Research Roundup: Cholera vaccine technology transfer, TB vaccine Phase 3 trial, Promising HIV drug candidates

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

March 18, 2024

Research Roundup: Promising Ebola drug, Unique nasal COVID vaccines trial, New research into sandfly that spreads leishmaniasis

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

March 15, 2024

Policy Cures Research and GHTC's new report on the returns from US investment in global health R&D featured in news articles

The newly published report from GHTC and Policy Cures Research, Doing Well by Doing Good: Why Investing in Global Health R&D Benefits the United States and the World, which looks at the returns from US investment in global health R&D, was featured in articles from Research Professional News, CIDRAP, and Infosalus.

March 14, 2024

New Report Finds Public Spending on Global Health Innovation Delivers Blockbuster Returns, Saving Lives While Generating Billions of Dollars in Benefits Globally and Domestically

Over the last 16 years, US government funding for R&D targeting global health challenges supported dozens of breakthrough innovations while generating billions of dollars in economic benefits, both global and domestic, and spurring a surge of industry investments, according to a new analysis from GHTC and Policy Cures Research.